CAFC Updates

Intuitive appeals from a final written decision of the Board upholding the patentability of claims 24–26 of U.S. Patent No. 8,479,969 relating...

Adapt appeals the District Court’s final judgment of invalidity with respect to several patents related to methods of treating opioid overdose by...

Velodyne and Quanergy both market products employing laser systems. Quanergy filed two inter partes review (“IPR”) proceedings challenging the validity of multiple claims...

Myco began marketing a product for treating blepharitis called the AB Max at a trade show. A month later, BlephEx filed an application...

Qualcomm appeals from two related IPR decisions of the Board finding several claims of Qualcomm’s U.S. Patent No. 8,063,674 unpatentable under 35 U.S.C....

Nature Simulation Systems, who owns United States Patents Nos. 10,120,961 and 10,109,105, both entitled “Method for Immediate Boolean Operations Using Geometric Facets,” sued Autodesk...

Evolusion sued Juggernaut alleging that Juggernaut’s “Hellfighter Mod Kits” infringe U.S. Patent No. 8,756,845 relating to a device and method for converting a semi-automatic...

Novartis markets a daily dose of fingolimod hydrochloride under the brand name Gilenya to treat relapsing remitting multiple sclerosis. HEC filed an Abbreviated...

Qualcomm owns U.S. Patent No. 8,838,949, which claims systems for efficiently retrieving an executable software image...

AstraZeneca sued for infringement of all claims of U.S. Patent Nos. 7,759,328; 8,143,239<span style="font-weight:...